相关实验视频
Updated: May 24, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
无塑性甲状腺癌:预测因素的相互作用,治疗挑战和生存洞察力
Asad Ullah1, Kavita Prasad2, Asim Ahmed3
1Department of Pathology, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
Expert review of endocrinology & metabolism
|February 28, 2025
概括
无塑性甲状腺癌 (ATC) 主要影响70多岁的白人女性. 老年,较大的瘤和转移性疾病与这种侵袭性甲状腺癌的较差结果有关.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 甲状腺癌研究研究
背景情况:
- 无塑性甲状腺癌 (ATC) 是一种罕见且具有攻击性的甲状腺瘤.
- 了解其人口结构和临床病理因素对于改善患者的治疗结果至关重要.
研究的目的:
- 进行最大和最最新的ATC人口统计和临床病理因素分析.
- 确定与ATC预后相关的独立风险因素.
主要方法:
- 数据是从监测,流行病学和最终结果 (SEER) 数据库中提取的.
- 分析包括1769个ATC病例.
- 进行多变量分析以确定风险因素.
主要成果:
- 诊断时的中位数年龄为71岁,其中59%的患者是女性.
- 最常见的转移部位是肺部 (40.7%).
- 5年总生存率 (OS) 为7.3%,癌症特异性生存率 (CSS) 为11.8%. 组合疗法 (辅助化学辐射的手术) 显示了最高的5年生存率 (20.9%).
- 预后更差的独立风险因素包括年龄>60岁,亚洲/太平洋岛民种族,瘤大小>2厘米和转移性疾病.
结论:
- ATC主要影响70多岁的白人女性.
- 年龄较大,亚洲/太平洋岛民种族和较大的瘤大小与更差的预后有关.
- 未来的临床试验应涵盖多种种族和性别,并纳入基因组分析,以更好地理解病变发生.
相关概念视频
Cancer Survival Analysis
319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K

